These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9988866)

  • 1. Current aspects of biology, risk assessment, and treatment of neuroblastoma.
    Haase GM; Perez C; Atkinson JB
    Semin Surg Oncol; 1999 Mar; 16(2):91-104. PubMed ID: 9988866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors.
    Ahmed AA; Zhang L; Reddivalla N; Hetherington M
    Pediatr Hematol Oncol; 2017 Apr; 34(3):165-185. PubMed ID: 28662353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent biologic and genetic advances in neuroblastoma: Implications for diagnostic, risk stratification, and treatment strategies.
    Newman EA; Nuchtern JG
    Semin Pediatr Surg; 2016 Oct; 25(5):257-264. PubMed ID: 27955728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroblastoma: biology, prognosis, and treatment.
    Park JR; Eggert A; Caron H
    Pediatr Clin North Am; 2008 Feb; 55(1):97-120, x. PubMed ID: 18242317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.
    Owens C; Irwin M
    Crit Rev Clin Lab Sci; 2012; 49(3):85-115. PubMed ID: 22646747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
    Matthay KK; Perez C; Seeger RC; Brodeur GM; Shimada H; Atkinson JB; Black CT; Gerbing R; Haase GM; Stram DO; Swift P; Lukens JN
    J Clin Oncol; 1998 Apr; 16(4):1256-64. PubMed ID: 9552023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review.
    Kushner BH; Cheung NK; LaQuaglia MP; Ambros PF; Ambros IM; Bonilla MA; Ladanyi M; Gerald WL
    J Clin Oncol; 1996 Jul; 14(7):2174-80. PubMed ID: 8683252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroblastoma.
    Shah S; Ravindranath Y
    Indian J Pediatr; 1998; 65(5):691-705. PubMed ID: 10773924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical management and outcome of locoregional neuroblastoma: comparison of the Childrens Cancer Group and the international staging systems.
    Haase GM; Atkinson JB; Stram DO; Lukens JN; Matthay KK
    J Pediatr Surg; 1995 Feb; 30(2):289-94; discussion 295. PubMed ID: 7738753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
    Zhao W; Sun Q; Xie Y; Hua Y; Xiong H; Jia J; Lu X
    Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):540-3. PubMed ID: 25224062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the diagnosis and treatment of neuroblastoma.
    Weinstein JL; Katzenstein HM; Cohn SL
    Oncologist; 2003; 8(3):278-92. PubMed ID: 12773750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroblastoma: an enigmatic disease.
    Brossard J; Bernstein ML; Lemieux B
    Br Med Bull; 1996 Oct; 52(4):787-801. PubMed ID: 9039732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
    Pérel Y; Valteau-Couanet D; Michon J; Lavrand F; Coze C; Bergeron C; Notz A; Plantaz D; Chastagner P; Bernard F; Thomas C; Rubie H
    Arch Pediatr; 2004 Jul; 11(7):834-42. PubMed ID: 15234382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology and treatment of neuroblastoma.
    Castleberry RP
    Pediatr Clin North Am; 1997 Aug; 44(4):919-37. PubMed ID: 9286292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
    Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
    Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroblastoma.
    Castleberry RP
    Eur J Cancer; 1997 Aug; 33(9):1430-7; discussion 1437-8. PubMed ID: 9337686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pediatric Oncology Group experience with the international staging system criteria for neuroblastoma. Member Institutions of the Pediatric Oncology Group.
    Castleberry RP; Shuster JJ; Smith EI
    J Clin Oncol; 1994 Nov; 12(11):2378-81. PubMed ID: 7964953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroblastoma.
    Humpl T
    World J Urol; 1995; 13(4):233-9. PubMed ID: 8528298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification.
    Laprie A; Michon J; Hartmann O; Munzer C; Leclair MD; Coze C; Valteau-Couanet D; Plantaz D; Carrie C; Habrand JL; Bergeron C; Chastagner P; Défachelles AS; Delattre O; Combaret V; Bénard J; Pérel Y; Gandemer V; Rubie H;
    Cancer; 2004 Sep; 101(5):1081-9. PubMed ID: 15329919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.